London, Oxford, UK. Tuesday, 2nd June 2020. Navenio, the healthcare scale-up whose location-based technology has been shown to double the throughput of hospital teams, has received c. £50k from the UK government and Innovate UK, the UK’s innovation agency, as part of a government boost for cutting-edge companies.
Navenio, a spin-out of Oxford University, provides infrastructure-free indoor location solutions, the equivalent of GPS for use indoors, to power a range of apps and platforms in sectors including healthcare.
Hospitals use Navenio’s AI-led ‘Intelligent Workforce Solution’ (IWS) to assign tasks to healthcare teams based on their location. This helps prioritise workload in real-time on the basis of ‘right person, right time, right place’. The secure system uses smartphones, with no need for investment in new infrastructure from hospital management.
Out of 8,600 applications, the funding was awarded to Navenio by Innovate UK, as part of a wider £40m investment in fewer than 800 businesses, to further develop its IWS solution. The money will enable hospital teams to use IWS for business continuity planning, to handle higher case workload, and to rapidly train and on-board new staff. Other projects benefitting from the funding include virtual reality training platforms for surgeons, virtual farmers’ markets and further innovations borne out of the coronavirus pandemic.
Business Secretary Alok Sharma commented:
“The coronavirus crisis has created challenges that impact the way we live, work and travel, but has also prompted a wave of new innovations as businesses look at ways to solve some of the challenges facing our world today. This funding will support UK start-ups to deliver potential solutions, services and ways of working, and help ensure the long-term sustainability of these businesses.”
As part of a three-month development project, Navenio plans to deliver a significantly enhanced IWS solution, specifically targeting improvements across infection control rapid response cleaning, porter tasking and task management – which is critical not only for dealing with Covid-19 itself, but also the surge of demand as hospitals deal with a large case backlog.
Tim Weil, CEO of Navenio, added: “The long-lasting effects of Covid-19 demands the rapid deployment of logistics teams across hundreds of hospitals, both UK and worldwide. This funding from Innovate UK will help dramatically improve patient flow within hospitals, which in turn will free up beds for new patients and help make sure that scarce resources are available to those who need it most, as well as help protect the frontline staff we all rely on so much.”
ENDS
About Navenio
Navenio was spun out of the University of Oxford in 2015 and has an established team of more than 60 people which continues to grow. Navenio is a finalist in the KPMG British Tech Pioneers 2020 Programme and its technology has won both commercial and academic awards. Academic Founder Professor Niki Trigoni won CTO of the Year at the 2020 Women in IT Awards.
Navenio’s location technology is developed from world-class University of Oxford science. In brief, using only a smartphone’s sensors, the fusion of four unique technologies creates a highly scalable indoor location, providing actionable insight immediately. Privacy and security are inherent within the Navenio technology and the company is Cyber Essentials certified, GDPR and NHS Data Security and Protection Toolkit compliant.
About Innovate UK
Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government. For more information, visit the UK Research and Innovation website.
We drive productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.
Contact information
UK/EU: Edward Clark, eclark@thecommsco.com
US/APAC: Jennifer Reid, jreid@thecommsco.com
Source: RealWire
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…